Improving prospects of the pharma industry, growth in the global generics market, expanded product portfolio and cost reduction initiatives will boost Biocon’s future performance.
from Personal Finance News-Wealth-Economic Times https://ift.tt/4r18b7T
No comments:
Post a Comment